Market Value1,642,718,000
Total Holdings64
File Date2017-08-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BPMC / Blueprint Medicines Corporation
GWP / GW Pharmaceuticals plc
EHTH / eHealth, Inc.
INSM / Insmed Incorporated
NKTR / Nektar Therapeutics
PBYI / Puma Biotechnology, Inc.
JUNO / Juno Therapeutics, Inc.
CASC / Cascadian Therapeutics, Inc.
PRXL / PAREXEL International Corp.
FATE / Fate Therapeutics, Inc.
BOLD / Boundless Bio, Inc.
AMED / Amedisys, Inc.
OVID / Ovid Therapeutics Inc.
JNCE / Jounce Therapeutics Inc
NXTM / NxStage Medical, Inc.
MEDP / Medpace Holdings, Inc.
GLYC / GlycoMimetics, Inc.
MOH / Molina Healthcare, Inc.
SPNC / Spectranetics Corp. (The)
MODN / Model N, Inc.
018490100 / Allergan plc
XNCR / Xencor, Inc.
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
SYNH / Syneos Health Inc - Class A
SGEN / Seagen Inc
SYRS / Syros Pharmaceuticals, Inc.
RARX / Ra Pharmaceuticals, Inc.
LJPC / La Jolla Pharmaceutical Co.
SGRY / Surgery Partners, Inc.
ESRX / Express Scripts Holding Co.
US29266S3040 / Endologix, Inc.
EW / Edwards Lifesciences Corporation
AVXS / AveXis, Inc.
PBYI / Puma Biotechnology, Inc. Call
ACRS / Aclaris Therapeutics, Inc.
CTMX / CytomX Therapeutics, Inc.
DPLO / Diplomat Pharmacy, Inc.
PTHN / Patheon N.V.
/ Oxford Immunotec Global PLC
NSTG / NanoString Technologies, Inc.
CSLT / Castlight Health Inc - Class B
PRQR / ProQR Therapeutics N.V.
ADVM / Adverum Biotechnologies, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
NDRM / NeuroDerm Ltd.
INCY / Incyte Corporation
/ Immunomedics, Inc.
BKD / Brookdale Senior Living Inc.
AGIO / Agios Pharmaceuticals, Inc.
DVAX / Dynavax Technologies Corporation
CMRX / Chimerix, Inc.
ICUI / ICU Medical, Inc.
/ Array BioPharma, Inc.
FOLD / Amicus Therapeutics, Inc.
CLVS / Clovis Oncology Inc
GBT / Global Blood Therapeutics Inc.
UNH / UnitedHealth Group Incorporated
CTLT / Catalent, Inc.
PRTA / Prothena Corporation plc
MCK / McKesson Corporation
WVE / Wave Life Sciences Ltd.
CNC / Centene Corporation
AUPH / Aurinia Pharmaceuticals Inc.
NBIX / Neurocrine Biosciences, Inc.
ELV / Elevance Health, Inc.
IMGN / ImmunoGen, Inc.
CLVS / Clovis Oncology Inc Call
IRTC / iRhythm Technologies, Inc.
BSX / Boston Scientific Corporation
CRL / Charles River Laboratories International, Inc.
RGNX / REGENXBIO Inc.
LIVN / LivaNova PLC
NVTA / Invitae Corporation
PEN / Penumbra, Inc.
ATRA / Atara Biotherapeutics, Inc.